Beta Bionics, Inc. Common Stock

BBNXNASDAQ • USD
ThemeMedical Devices & HealthTech›Wearable Medical Devices
16.86 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
16.85
↘ 0.01 (0.06%)
POST MARKET (AS OF 04:10 PM EDT)
Post Market
AS OF 04:10 PM EDT
16.85
↘ 0.01 (0.06%)
🔴Market: CLOSED

Beta Bionics, Inc. Common Stock (BBNX) trades at $16.84 per share. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, BBNX trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jul 15, 2026.

Open?$16.89
High?$17.87
Low?$16.36
Prev. Close?$16.86
Volume?1.7M
Avg. Volume?1.1M
VWAP?$17.12
Rel. Volume?1.63x
Bid / Ask
Bid?$15.50 × 500
Ask?$18.66 × 500
Spread?$3.16
Midpoint?$17.08
Valuation & Ratios
Market Cap?751.3M
Shares Out?44.6M
Float?37.7M
Float %?84.8%
P/E Ratio?N/A
P/B Ratio?2.77
EPS?-$1.49
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
Themes
Medical Devices & HealthTech›Wearable Medical DevicesDigital Health & Telemedicine›Remote Patient Monitoring
Employees
423
Market Cap
751.3M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
www.betabionics.com
Listed
2025-01-30
Address
11 HUGHES
IRVINE, CA 92618
Phone: 949-427-7785
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
98
Short Sent.?
21
Piotroski F-Score?0/9Weak
Altman Z-Score?12.20Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?18.11%High
Short Interest?6.8M
Days to Cover?5.9
Free Float37.7M
Avg Daily Volume1.2M
Settlement Date2026-06-30
Financial Health
Current Ratio?10.69Strong
Quick Ratio?9.67Strong
Cash Ratio?1.30Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
75/100
P/E?
N/A▾
P/B?
Peers
100
S&P
59
2.77CHEAP▾
P/S?
Peers
100
S&P
18
6.82FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-9.6CHEAP▾
EV/Sales?
Peers
100
S&P
23
6.54HIGH▾
Returns & Efficiency
ROE?
S&P
7
-24.5%WEAK▾
ROA?
S&P
3
-21.8%WEAK▾
Cash Flow & Enterprise
FCF?$-61123000
Enterprise Value?$721.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist